FIELD: pharmaceutical industry. SUBSTANCE: described are new compounds of general formula I: α- wherein Q, A, 
, n and m are as defined in the claims. Said compounds have fermentative activity of catalytic domains of human stromalysine and leucocyte collagenase. EFFECT: improved properties of the title compounds. 4 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED 6- AND 7-AMINOTETRAHYDROISOQUINOLINE CARBOXYLIC ACIDS | 1998 |
|
RU2212405C2 |
| SUBSTITUTED DIAMINOCARBOXYLIC ACIDS | 1998 |
|
RU2196768C2 |
| 2,5-SUBSTITUTED TETRAHYDROISOQUINOLINE AND A PHARMACEUTICAL MODULATION COMPOSITION 5-НТ6 | 2004 |
|
RU2327689C2 |
| DERIVATIVES OF HYDROXYMETHYLFURAZAN CARBOXYLIC ACID AND PHARMACEUTICAL PREPARATION | 1994 |
|
RU2134687C1 |
| FIVE-MEMBERED HETEROCYCLES AS INHIBITORS OF LEUKOCYTE ADHESION AND VLA-4 ANTAGONISTS | 1997 |
|
RU2229296C2 |
| INOSITOL GLYCANS WITH INSULIN-LIKE EFFECT, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1997 |
|
RU2178794C2 |
| COMPOUNDS | 2003 |
|
RU2327690C2 |
| ANTAGONISTS OF VITRONECTIN RECEPTOR, THEIR PREPARING AND APPLICATION | 1997 |
|
RU2198892C2 |
| SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINES, METHOD OF THEIR OBTAINING, THEIR APPLICATION AS MEDICATIONS, AND MEDICATIONS CONTAINING THEM | 2004 |
|
RU2343147C2 |
| NEW CYCLOALKYL DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND ANTAGONISTS OF VITRONECTINE RECEPTOR | 1997 |
|
RU2180331C2 |
